Stay updated on Locally Advanced Lung Cancer Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the Locally Advanced Lung Cancer Immunotherapy Clinical Trial page.

Latest updates to the Locally Advanced Lung Cancer Immunotherapy Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.7%
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check33 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check62 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check76 days agoChange DetectedThe web page has undergone significant updates, including the addition of the study title 'Phase II Study of Consolidation Immunotherapy With Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer (NSCLC): BTCRC-LUN16-081' and the revision number has been updated from v2.14.4 to v2.15.0. Additionally, the collaborators have been specified as Bristol-Myers Squibb and the Big Ten Cancer Research Consortium.SummaryDifference54%
- Check83 days agoChange DetectedThe page has updated its version from v2.14.3 to v2.14.4 and removed a date of March 25, 2025, while adding two new dates: March 11, 2025, and February 6, 2025.SummaryDifference0.4%
Stay in the know with updates to Locally Advanced Lung Cancer Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Locally Advanced Lung Cancer Immunotherapy Clinical Trial page.